A nationwide cohort analysis to determine the prevalence of sinus node dysfunction and rates of pacemaker implantation in systemic lupus erythematosus

被引:0
作者
Gonuguntla, Karthik [1 ]
Ejaz, Komal [2 ]
Rojulpote, Chaitanya [2 ]
Shaik, Ayesha [1 ]
Bhattaru, Abhijit [5 ]
Buch, Tapan [3 ]
Avula, Sreekant [2 ]
Rauniyar, Rahul [2 ]
Singh, Vijay [2 ]
Karambelkar, Pranav [2 ]
Narayanareddy, Pranathi [6 ]
Kela, Kashyap [2 ]
Cowden, Richard G. [4 ]
Perosevic, Nikola [1 ]
Boruah, Pranjal [7 ]
机构
[1] Univ Connecticut, Dept Med, Farmington, CT 06032 USA
[2] Wright Ctr Grad Med Educ, Dept Med, 501 S Washington Ave, Scranton, PA 18508 USA
[3] Wright Ctr Grad Med Educ, Dept Cardiol, Scranton, PA USA
[4] Univ Free State, Dept Psychol, Bloemfontein, South Africa
[5] Univ Penn, Dept Nucl Cardiol, Philadelphia, PA USA
[6] Univ Penn, Dept Med, Penn Hosp, Philadelphia, PA USA
[7] Geisinger Community Med Ctr, Dept Cardiol, Scranton, PA USA
关键词
SLE; pacemaker; sinus node dysfunction; NIS; RISK-FACTORS; COMPLICATIONS; THERAPY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic lupus erythematosus (SLE) has been known to have various degrees of cardiac involvement. However, limited evidence exists on prevalence of heart rhythm disorders in patients with SLE who have subsequent pacemaker (PM) implantation. The purpose of this study was to examine the prevalence of sinus node dysfunction (SND) in patients with SLE. The data was retrospectively analysed from the National Inpatient Sample database for the years 2010 to 2014 using the International Classification of Disease-9 diagnosis codes for SLE and SND in patients 18 years or older. We analysed data of 158,368 patients with SLE that were admitted from 2010 to 2014. The sample of patients ranged between 18 and 101 years of age (M = 52.13 +/- 17.61), were primarily female (88.2%), and were Caucasian (50.6%). The prevalence of SND was 4.3%. In patients with both SLE and SND, the prevalence of PM implantation over the five-year period of analysis was 3.6% and the majority of these patients had a dual-chamber PM (85.6%). Prevalence rates of SND in patients with SLE increased for females over this five-year period (p = 0.023). Prevalence estimates of complications associated with PM in patients with SLE and SND were venous thromboembolism (2.1%), cardiac tamponade (0.4%), sepsis and severe sepsis (0.4%), septic shock (0%), pneumothorax (0%) and PM site hematoma (1.7%). The findings of this study revealed that the prevalence of SND and the prevalence of PM in patients with both SLE and SND have remained relatively consistent over the five years that our study analysed.
引用
收藏
页码:478 / 483
页数:6
相关论文
共 50 条
[31]   Diabetes mellitus complicating systemic lupus erythematosus - analysis of the UCL lupus cohort and review of the literature [J].
Cortes, S. ;
Chambers, S. ;
Jeronimo, A. ;
Isenberg, D. .
LUPUS, 2008, 17 (11) :977-980
[32]   Hydroxychloroquine Serum Concentrations and Flares of Systemic Lupus Erythematosus: A Longitudinal Cohort Analysis [J].
Mok, Chi Chiu ;
Penn, Hannah J. ;
Chan, Kar Li ;
Tse, Sau Mei ;
Langman, Loralie J. ;
Jannetto, Paul J. .
ARTHRITIS CARE & RESEARCH, 2016, 68 (09) :1295-1302
[33]   Identification of Key Biomarkers in Systemic Lupus Erythematosus by a Multi-Cohort Analysis [J].
Wei, Meilin ;
Dong, Qiguan ;
Chen, Shaoqiu ;
Wang, Junlong ;
Yang, Hua ;
Xiong, Qin .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[34]   Trends of Lymphomas in Patients With Systemic Lupus Erythematosus and Exploring Its Cardiovascular Outcomes: A Nationwide Analysis [J].
Sanikommu, Dhruvi Reddy ;
Tamez, Mariana Vanoye ;
Patel, Neel ;
Nadeem, Ahmed .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 :S450-S451
[35]   Incidence and survival impact of pulmonary arterial hypertension among patients with systemic lupus erythematosus: a nationwide cohort study [J].
Chen, Hung-An ;
Hsu, Tsai-Ching ;
Yang, Su-Ching ;
Weng, Chia-Tse ;
Wu, Chun-Hsin ;
Sun, Chien-Yao ;
Lin, Chun-Yu .
ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
[36]   Pacemaker-Based Analysis of Atrioventricular Conduction and Atrial Tachyarrhythmias in Patients with Primary Sinus Node Dysfunction [J].
Stockburger, Martin ;
Trautmann, Frederike ;
Nitardy, Aischa ;
Schade, Stefan ;
Celebi, Oezlem ;
Krebs, Alice ;
Dietz, Rainer .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2009, 32 (05) :604-613
[37]   A meta-analysis of secondary osteoporosis in systemic lupus erythematosus: prevalence and risk factors [J].
Chaoyu Gu ;
Rui Zhao ;
Xiaomei Zhang ;
Zhifeng Gu ;
Wei Zhou ;
Yilin Wang ;
Jiaxin Guo ;
Yanfeng Bao ;
Chi Sun ;
Chen Dong ;
Jianlin Gao .
Archives of Osteoporosis, 2020, 15
[38]   The prevalence and burden of systemic lupus erythematosus in a medicare population: retrospective analysis of medicare claims [J].
Garris, Cindy ;
Shah, Manan ;
Farrelly, Eileen .
COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2015, 13
[39]   The prevalence and burden of systemic lupus erythematosus in a medicare population: retrospective analysis of medicare claims [J].
Cindy Garris ;
Manan Shah ;
Eileen Farrelly .
Cost Effectiveness and Resource Allocation, 13
[40]   Statin reduces mortality and morbidity in systemic lupus erythematosus patients with hyperlipidemia: A nationwide population-based cohort study [J].
Yu, Hsin-Hui ;
Chen, Pau-Chung ;
Yang, Yao-Hsu ;
Wang, Li-Chieh ;
Lee, Jyh-Hong ;
Lin, Yu-Tsan ;
Chiang, Bor-Luen .
ATHEROSCLEROSIS, 2015, 243 (01) :11-18